Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Domain Therapeutics and Explicyte Enter Partnership Agreement in Immuno-oncology
Domain Therapeutics, a biopharmaceutical company specializing in the discovery and development of new drugs targeting […]
Novo Nordisk Expands Research Collaboration in Novel Delivery Technologies for Biologic Medicines
Novo Nordisk today announced the expansion of its existing research collaboration in oral drug delivery […]
Fluent BioSciences Awarded $1.7 Million SBIR Grant to Commercialize PIPseq™, a Breakthrough Platform Technology Enabling Scalable, Sensitive Single-cell Analysis in Any Laboratory
Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every […]
Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases
Scenic Biotech BV (“Scenic”), a pioneer in the discovery of genetic modifiers to enable the […]
Artificial Retinal Device Mimics Human Optical Illusions: WPI-MANA
A team at the International Center for Materials Nanoarchitectonics (WPI-MANA) has developed the first-ever artificial retinal […]
Flow Eighteen38 Receives €5 Million EUR (c.$5.58 Million USD) to Expand Production and Biophysical Capabilities
Flow Eighteen38, a protein sciences division created to facilitate and accelerate antibody characterization and protein […]
HCS Pharma Expects 90% Success Rate on Cancer Drugs Tests Due to Recreation of Organs In-vitro with BIOMIMESYS® Technology
Cancer is the second cause of death in the world and has been steadily increasing […]
Cannabotech's "Integrative-Colon" Products Eliminated Over 90% of Colon Cancer Cells in a Cell Model Experiment
Cannabotech, a biomedical company developing oncological products based on cannabis and mushroom extracts, reports cell […]
Solvias Appoints Archie Cullen Chief Executive Officer
Solvias, one of the largest independent analytical testing, contract research, development and manufacturing companies, today […]
Genetic Study Gives Extensive Insights into Severe Covid-19
The world’s largest study of the genetics of critical Covid-19, involving more than 57,000 people, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more